SynBioSe-2: Synergetic B-cell Immunomodulation in SLE - 2nd Study. (clinicaltrials.gov) - Oct 8, 2026 - P3 | N=71 | Completed | Sponsor: Leiden University Medical Center | Active, not recruiting ➔ Completed | Trial primary completion date: Jun 2024 ➔ Jun 2026
Trial completion • Trial primary completion date • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|